
Research PaperRAD001 (everolimus) attenuates experimental autoimmune neuritis by inhibiting the mTOR pathway, elevating Akt activity and polarizing M2 macrophages
Keywords: GBS; Guillain-Barre' syndrome; EAN; experimental autoimmune neuritis; mTOR; mammalian target of rapamycin; PNS; peripheral nervous system; PBS; phosphate-buffered saline; dpi; days post-immunization; EMG; electromyography; CMAP; compound muscle action pot